| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.90M | - | |
| CFO | 215.4K | $2.05M | - | |
| Dir | 119.9K | $1.14M | - | |
| VP | 104.1K | $989.0K | - | |
| Dir | 89.0K | $845.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Richard Ronald | Director | Sale+OE | 21,984 | $11.97 | $263,077.09 | -10.0% | -29.1% | - | |
| Nov 10, 2025 | Degolyer Donald W54 | Director | Sell | 17,801 | $10.54 | $187,622.54 | -12.9% | +0.4% | - | |
| Nov 7, 2025 | Dayal Sujata Tyagi | Director | Sell | 8,552 | $10.00 | $85,520.00 | -8.8% | +3.7% | - | |
| Oct 7, 2025 | Glessner Coleen | EVP, Quality &Ethics, And Cpl | Sell | 30,608 | $10.00 | $306,080.00 | -17.5% | +29.5% | - | |
| Aug 15, 2025 | Zoon Kathryn C62 | Director | Sell | 7,086 | $8.87 | $62,852.82 | -9.0% | +16.7% | - | |
| Aug 12, 2025 | Degolyer Donald W54 | Director | Sell | 7,844 | $8.65 | $67,830.99 | -5.4% | +23.3% | - | |
| May 23, 2025 | Katkin Keith69 | Director | Sell | 7,844 | $6.30 | $49,417.20 | -8.3% | +45.6% | - | |
| May 13, 2025 | Papa Joseph C | President And CEO | Buy | 60,000 | $5.83 | $349,800.00 | +21.2% | +38.8% | - | |
| Mar 12, 2025 | Fowler Neal Franklin | Director | Sell | 35,000 | $5.83 | $204,050.00 | -25.7% | +9.8% | +32.2% | |
| Mar 12, 2025 | Zoon Kathryn C62 | Director | Sell | 10,000 | $5.73 | $57,300.00 | -18.4% | +9.8% | +32.2% |